Ines Donangelo is an Endocrinology/Metabolic physician affiliated with University of California, Los Angeles. OpenAlex indexes 48 publications with 652 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RECORDATI_RARE_DISEASES_INC.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
59.9%GLP-1 receptor agonist17.2%Mounjaro39%Ozempic37%Trulicity17%Rybelsus8%Part D≥66 patientsInsulin Analog12.3%Lantus Solostar25%Humalog Kwikpen U-10018%Basaglar Kwikpen U-10012%Tresiba Flextouch U-10012%Fiasp Flextouch7%Insulin Lispro Kwikpen U-1007%Novolog Flexpen7%Toujeo Solostar3%Insulin Aspart Flexpen3%Tresiba Flextouch U-2002%Humalog2%Lyumjev2%Part D<11 patients+ 8 more classes in this area
Hormonal (systemic)
19.2%l-Thyroxine17%Levothyroxine Sodium70%Synthroid28%Tirosint2%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1%Methimazole100%Part D≥12 patients+ 3 more classes in this area
Cardiovascular
17.6%Statin10.1%Atorvastatin Calcium68%Rosuvastatin Calcium22%Pravastatin Sodium10%Part D≥89 patientsCholesterol absorption inhibitor1.4%Ezetimibe100%Part D≥14 patients+ 8 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reconsidering Diagnostic Cutoffs for Prolactin in Pituitary Adenomas: Impact of Sex, Age, and Tumor Size
Journal of Neurological Surgery Part B Skull Base
2026 - Neuroendocrine Tumor of the Breast in a Young Woman With MEN2A Syndrome
AACE Endocrinology and Diabetes
2026 - Cushing Disease Clinical Phenotype and Tumor Behavior Vary With Age: Diagnostic and Perioperative Implications
The Journal of Clinical Endocrinology & Metabolism
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Kamyar Kalantar-Zadeh, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”